Repurposing the Antipsychotic Drug Chlorpromazine as Adjuvant Therapeutic Agent for Resected Stage III Colon Cancer
Clinical trial NCT05433402 · WITHDRAWN
Trial details
- NCT number
- NCT05433402
- Sponsor
- Sadat City University
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-20
- Primary completion
- 2022-09-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.